Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2
Research output: Contribution to journal › Letter › Research › peer-review
| Original language | English |
|---|---|
| Journal | Diabetes, Obesity and Metabolism |
| Volume | 23 |
| Issue number | 6 |
| Pages (from-to) | 1397-1401 |
| Number of pages | 5 |
| ISSN | 1462-8902 |
| DOIs | |
| Publication status | Published - 1 Jun 2021 |
Links
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014019/pdf/DOM-23-1397.pdf
Final published version
ID: 280290468